AHLR is the leading organization comprising the world’s most esteemed scientists dedicated to studying the mechanisms of aging and developing interventions to slow and reverse the process. Its members are elected annually based on their significant scientific contributions and commitment to the community.

Academy for Health and Lifespan Research

UConn John Dempsey Hospital

Aging Augments the Impact of Influenza Respiratory Tract Infection on Mobility Impairments, Muscle-Localized Inflammation, and Muscle Atrophy

Human Longevity is Influenced by Many Genetic Variants: Evidence from 75,000 UK Biobank Participants

A Geriatric Perspective on Benign Paroxysmal Positional Vertigo

T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines

Any Versus Long-Term Prescribing of High Risk Medications in Older People Using 2012 Beers Criteria: Results from Three Cross-Sectional Samples of Primary Care Records for 2003/4, 2007/8 and 2011/12

The University of Connecticut (UConn) is one of America’s top 20 public universities, according to U.S. News & World Report. It is home to more than 31,000 students, 1,300 faculty, 230,000 proud alumni, and a handsome husky named Jonathan.

The University has fourteen schools and colleges: Agriculture and Natural Resources, Business, Dental Medicine, Education, Engineering, Fine Arts, Law, Liberal Arts and Sciences, Medicine, Nursing, Pharmacy, and Social Work. Students can choose from eight undergraduate bachelor's degrees with 102 possible majors, as well as seventeen graduate/doctoral degrees and five professional degree programs (MD, JD, etc.).

UConn's main campus in Storrs is admitting the highest-achieving freshmen in University history. Student diversity continues to increase, as does the number of honors students, valedictorians and salutatorians who consistently make UConn their top choice. It's a great time to be a Husky!

University of Connecticut

My research has always been translational, seeking to define and target risk and mechanistic pathways contributing to functional declines involving voiding, cognition, mobility and host defense. In order to move the field from a description of associations to an understanding of mechanisms, my colleagues and I have sought to overcome barriers between studies involving human subjects and research conducted using cells and animal models. Thus, over the years my own research activities have moved back and forth between the bench and more clinical and translational settings. 

My ability to accomplish these scientific objectives and to also mentor trainees involving such multifaceted experimental approaches is made possible by the fact that the UConn Center on Aging is the multidisciplinary home to clinical investigators, population and social scientists, as well as basic researchers - all supported by a total research portfolio exceeding $ 40 million. 

At the UConn Center on Aging, we have established a research program focused on Precision Gerontology. This is an effort to leverage discoveries in the gerontological sciences towards the development of clinical interventions that are more precise and effective by virtue of better addressing increasing variability between individuals with aging. To that end, we are focused on defining risk factors and mechanisms that are implicated in both aging and chronic diseases, using such information to design more specific and effective interventions. Such efforts are enabled by the fact that our Center is the multidisciplinary home to basic scientists, clinical investigators and population researchers whose work is supported by a broad funding portfolio.

Mobility and Frailty

Voiding Issues and Urinary Incontinence

Geroscience

Geriatric Medicine

Aging

Gerontology

Vaccines and Immunology of Aging

Delirium and Dementia

CT Doctor Discusses Vaccines to Fight RSV

The flu kills older adults more than anyone else. UConn and Jackson Lab are studying the immune system to learn more.

Which next-generation flu vaccines best boost immunity among older adults? A CT study seeks to find out.

CT team developing COVID drug to reverse aging ... really

VIDEO: Study Researches COVID's Impact on Seniors

ACC Geriatric Cardiology Member Section Virtual Section Meeting

What explains Covid-19’s lethality for the elderly? Scientists look to ‘twilight’ of the immune system

Select Inquiry Type